HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert J D'Amato Selected Research

Pathologic Neovascularization

11/2022Anti-angiogenic properties of microRNA-29a in preclinical ocular models.
9/2010Broad spectrum antiangiogenic treatment for ocular neovascular diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert J D'Amato Research Topics

Disease

12Neoplasms (Cancer)
10/2020 - 04/2002
10Endometriosis
07/2013 - 01/2005
6Corneal Neovascularization
11/2022 - 09/2008
5Choroidal Neovascularization
11/2022 - 11/2006
3Hypoxia (Hypoxemia)
01/2020 - 02/2008
3Retinal Neovascularization
01/2020 - 09/2010
2Pathologic Neovascularization
11/2022 - 09/2010
2Blindness (Hysterical Blindness)
01/2014 - 07/2009
2Macular Degeneration (Age-Related Maculopathy)
01/2014 - 11/2006
2Melanoma (Melanoma, Malignant)
04/2013 - 02/2008
2Inflammation (Inflammations)
01/2013 - 09/2010
1Glaucoma
12/2022
1Ischemia
05/2021
1Glioblastoma (Glioblastoma Multiforme)
10/2020
1Disease Progression
01/2020
1Retinal Vein Occlusion
01/2014
1Uveitis
01/2013
1Colonic Neoplasms (Colon Cancer)
06/2012
1Colorectal Neoplasms (Colorectal Cancer)
06/2012
1Oculocutaneous albinism type 2
01/2012
1Vascular Diseases (Vascular Disease)
12/2011
1Wounds and Injuries (Trauma)
02/2011
1Hypersensitivity (Allergy)
09/2010
1Neoplasm Metastasis (Metastasis)
07/2008
1Experimental Melanoma
02/2008
1Genetic Predisposition to Disease (Genetic Predisposition)
07/2004
1Hematologic Neoplasms (Hematological Malignancy)
04/2002
1Burkitt Lymphoma (Burkitt's Lymphoma)
04/2002
1B-Cell Lymphoma (Lymphoma, B Cell)
04/2002
1Multiple Myeloma
04/2002
1Rupture
04/2002

Drug/Important Bio-Agent (IBA)

10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2013 - 01/2006
6Proteins (Proteins, Gene)FDA Link
07/2013 - 09/2002
5Angiogenesis InhibitorsIBA
04/2011 - 04/2002
4lodaminIBA
01/2013 - 07/2008
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020 - 11/2003
3Retinaldehyde (Retinal)IBA
01/2014 - 12/2011
3Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
06/2012 - 07/2004
3EndostatinsIBA
06/2012 - 10/2005
3O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA
04/2011 - 04/2002
2Oxygen (Dioxygen)IBA
11/2022 - 01/2020
2Peptides (Polypeptides)IBA
05/2021 - 01/2006
2matrigelIBA
01/2014 - 09/2010
2Messenger RNA (mRNA)IBA
07/2013 - 02/2011
2Vascular Endothelial Growth Factor CIBA
07/2013 - 10/2011
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
10/2011 - 02/2008
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2008 - 01/2005
22-MethoxyestradiolIBA
02/2008 - 11/2006
1Thrombospondin 1IBA
12/2022
1Extracellular Matrix ProteinsIBA
12/2022
1Amino AcidsFDA Link
12/2022
1Amiodarone (Amiodarona)FDA LinkGeneric
10/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1Fibroblast Growth Factor 1 (FGF-1)IBA
01/2020
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2020
1Small Interfering RNA (siRNA)IBA
07/2013
1AC133 AntigenIBA
04/2013
1CytokinesIBA
01/2013
1Platelet-Derived Growth FactorIBA
06/2012
1Platelet Factor 4IBA
06/2012
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
10/2011
1TeaIBA
10/2011
1erucylphosphocholineIBA
04/2011
1salicylhydroxamic acid (SHAM)IBA
04/2011
1pimonidazoleIBA
02/2011
1PolymersIBA
09/2010
1Hypoxia-Inducible Factor 1IBA
02/2008
1anthrax toxin (anthrax lethal factor)IBA
10/2007
1AntigensIBA
10/2007
1Hormones (Hormone)IBA
09/2007
1SteroidsIBA
09/2007
1Bevacizumab (Avastin)FDA Link
01/2006
13-aminophthalimidoglutarimideIBA
04/2002
1glutarimideIBA
04/2002
1Thalidomide (Thalomid)FDA Link
04/2002
1AngiostatinsIBA
04/2002

Therapy/Procedure

11Therapeutics
01/2014 - 09/2002
4Lasers (Laser)
01/2014 - 11/2006
1Negative-Pressure Wound Therapy
02/2011
1Occlusive Dressings (Occlusive Dressing)
02/2011
1Pain Management
01/2005